Antal Rohit Desai - Sep 17, 2021 Form 4 Insider Report for PROCEPT BioRobotics Corp (PRCT)

Role
Director, 10%+ Owner
Signature
/s/ Alaleh Nouri, Attorney-in-Fact for Antal Rohit Desai
Stock symbol
PRCT
Transactions as of
Sep 17, 2021
Transactions value $
$11,000,000
Form type
4
Date filed
9/21/2021, 06:36 PM
Previous filing
Sep 14, 2021
Next filing
Mar 21, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PRCT Common Stock Conversion of derivative security +49.5K 49.5K Sep 17, 2021 By The 2:22 DNA Trust F1
transaction PRCT Common Stock Conversion of derivative security +10.1M +1445.34% 10.8M Sep 17, 2021 By White Tailed Ptarmigan, LP F1, F2
transaction PRCT Common Stock Purchase $11M +440K +4.08% $25.00 11.2M Sep 17, 2021 By White Tailed Ptarmigan, LP F2, F3
transaction PRCT Common Stock Conversion of derivative security +52.6K 52.6K Sep 17, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PRCT Series C Convertible Preferred Stock Conversion of derivative security -35.2K -100% 0 Sep 17, 2021 Common Stock 35.2K Direct F1
transaction PRCT Series E Convertible Preferred Stock Conversion of derivative security -7.28K -100% 0 Sep 17, 2021 Common Stock 7.28K Direct F1
transaction PRCT Series F Convertible Preferred Stock Conversion of derivative security -7.47K -100% 0 Sep 17, 2021 Common Stock 7.47K Direct F1
transaction PRCT Series G Convertible Preferred Stock Conversion of derivative security -2.67K -100% 0 Sep 17, 2021 Common Stock 2.67K Direct F1
transaction PRCT Series D Convertible Preferred Stock Conversion of derivative security -39.2K -100% 0 Sep 17, 2021 Common Stock 39.2K By The 2:22 DNA Trust F1
transaction PRCT Series E Convertible Preferred Stock Conversion of derivative security -9.1K -100% 0 Sep 17, 2021 Common Stock 9.1K By The 2:22 DNA Trust F1
transaction PRCT Series G Convertible Preferred Stock Conversion of derivative security -1.25K -100% 0 Sep 17, 2021 Common Stock 1.25K By The 2:22 DNA Trust F1
transaction PRCT Series D Convertible Preferred Stock Conversion of derivative security -4.71M -100% 0 Sep 17, 2021 Common Stock 4.71M By White Tailed Ptarmigan, LP F1, F2
transaction PRCT Series E Convertible Preferred Stock Conversion of derivative security -3.04M -100% 0 Sep 17, 2021 Common Stock 3.04M By White Tailed Ptarmigan, LP F1, F2
transaction PRCT Series F Convertible Preferred Stock Conversion of derivative security -2.06M -100% 0 Sep 17, 2021 Common Stock 2.06M By White Tailed Ptarmigan, LP F1, F2
transaction PRCT Series G Convertible Preferred Stock Conversion of derivative security -272K -100% 0 Sep 17, 2021 Common Stock 272K By White Tailed Ptarmigan, LP F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock, Series F Preferred Stock and Series G Preferred Stock converted automatically into one share of Common Stock upon the closing of the Issuer's initial public offering. These shares had no expiration date.
F2 Antal Desai, a member of our board of directors and a Partner of CPMG, Inc., along with Kent McGaughy, Jr., the sole shareholder and managing director of CPMG, Inc., may be deemed to share voting and investment power with respect to the shares beneficially owned by White Tailed Ptarmigan, LP. Mr. Desai disclaims beneficial ownership of the shares beneficially owned by White Tailed Ptarmigan, LP except to the extent of any pecuniary interest therein.
F3 Represents a purchase in the Issuer's public offering.